PL352683A1 - Kompozycja do zapobiegania zmęczeniu mięśni i do przystosowania mięśni szkieletowych do ćwiczesigmaforsownych - Google Patents

Kompozycja do zapobiegania zmęczeniu mięśni i do przystosowania mięśni szkieletowych do ćwiczesigmaforsownych

Info

Publication number
PL352683A1
PL352683A1 PL00352683A PL35268300A PL352683A1 PL 352683 A1 PL352683 A1 PL 352683A1 PL 00352683 A PL00352683 A PL 00352683A PL 35268300 A PL35268300 A PL 35268300A PL 352683 A1 PL352683 A1 PL 352683A1
Authority
PL
Poland
Prior art keywords
prevention
composition
muscle
adaptation
strenuous exercise
Prior art date
Application number
PL00352683A
Other languages
English (en)
Other versions
PL204743B1 (pl
Inventor
Claudio Cavazza
Original Assignee
Sigma-Tau Healthscience S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma-Tau Healthscience S.P.A. filed Critical Sigma-Tau Healthscience S.P.A.
Publication of PL352683A1 publication Critical patent/PL352683A1/pl
Publication of PL204743B1 publication Critical patent/PL204743B1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Vascular Medicine (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
PL352683A 1999-07-23 2000-07-21 Kompozycja farmaceutyczna do podawania doustnego, pozajelitowego, doodbytniczego lub przezskórnego i zastosowanie kompozycji do wytwarzania leku i dietetycznego środka spożywczego PL204743B1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT1999RM000467A IT1306173B1 (it) 1999-07-23 1999-07-23 Composizione per la prevenzione degli affaticamenti muscolari e permigliorare il rendimento energetico muscolare.
PCT/IT2000/000308 WO2001006873A1 (en) 1999-07-23 2000-07-21 Composition for the prevention of muscle fatigue and skeletal muscle adaptation to strenuous exercise

Publications (2)

Publication Number Publication Date
PL352683A1 true PL352683A1 (pl) 2003-09-08
PL204743B1 PL204743B1 (pl) 2010-02-26

Family

ID=11406897

Family Applications (1)

Application Number Title Priority Date Filing Date
PL352683A PL204743B1 (pl) 1999-07-23 2000-07-21 Kompozycja farmaceutyczna do podawania doustnego, pozajelitowego, doodbytniczego lub przezskórnego i zastosowanie kompozycji do wytwarzania leku i dietetycznego środka spożywczego

Country Status (21)

Country Link
US (1) US6602512B1 (pl)
EP (1) EP1196046B1 (pl)
AR (1) AR024820A1 (pl)
AT (1) ATE263496T1 (pl)
AU (1) AU778647B2 (pl)
CA (1) CA2377128C (pl)
CZ (1) CZ20023A3 (pl)
DE (1) DE60009704T2 (pl)
DK (1) DK1196046T3 (pl)
ES (1) ES2216931T3 (pl)
HU (1) HU228838B1 (pl)
IL (1) IL147408A0 (pl)
IT (1) IT1306173B1 (pl)
MX (1) MXPA02000780A (pl)
NO (1) NO20020337L (pl)
PL (1) PL204743B1 (pl)
PT (1) PT1196046E (pl)
SK (1) SK942002A3 (pl)
TN (1) TNSN00161A1 (pl)
TR (1) TR200200179T2 (pl)
WO (1) WO2001006873A1 (pl)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1316998B1 (it) * 2000-03-02 2003-05-26 Sigma Tau Healthscience Spa Composizione per la prevenzione e/o il trattamento degli effetticitotossici indotti dall'uso di agenti immunosoppressori.
US6849613B2 (en) 2001-08-29 2005-02-01 Kedar N. Prasad Multiple antioxidant micronutrients
US7449451B2 (en) * 2001-08-29 2008-11-11 Premier Micronutrient Corporation Use of multiple antioxidant micronutrients as systemic biological radioprotective agents against potential ionizing radiation risks
DE10160485A1 (de) * 2001-12-08 2003-10-02 Degussa Verwendung von Kreatin und/oder einem seiner physiologisch geeigneten Derivate zur Prävention oder Linderung von nicht krankheitsbedingten Beeinträchtigungen und/oder Störungen der Muskelfunktion
DE102004009962A1 (de) * 2004-03-01 2005-09-22 Degussa Ag Verwendung von Guanidin-Verbindungen als physiologisches Stärkungsmittel in Form von Nahrungsergänzungsmitteln, Futtermittelzusätzen, in kosmetischen Zubereitungen und als Pflanzenstärkungsmittel
US20060083793A1 (en) * 2004-09-29 2006-04-20 Gardiner Paul T Nutritional composition for promoting muscle performance and acting as hydrogen (H+) blocker
EP1904070A4 (en) * 2005-07-07 2009-09-02 H3 Formulations Ltd NUTRITIONAL SUPPLEMENT FOR IMPROVING SKELETAL MUSHROOMS, REDUCING MUSCLE PROTEIN DEGRADATION, DOWNGRADING MUSCLE CATABOLISM PATHS, AND REDUCING CATABOLISM OF MUSCLE CELLS
GB0606864D0 (en) * 2006-04-05 2006-05-17 Univ Nottingham Increades fatty acid oxidation
WO2008025114A1 (en) * 2006-08-30 2008-03-06 Aplodan Formulations Ltd. Increasing atp availability by inhibition of creatine kinase (ck) leakage resulting from high-intensity exercise
US7375097B2 (en) * 2006-08-30 2008-05-20 Aplodan Formulations Ltd. Increasing ATP availability by inhibition of creatine kinase (CK) leakage resulting from high-intensity exercise
US7368441B2 (en) * 2006-08-30 2008-05-06 Aplodan Formulations Ltd. Method of increasing intracellular concentrations of phosphate and increasing the force of muscular contractions
WO2008025115A1 (en) * 2006-08-30 2008-03-06 Aplodan Formulations Ltd. Method of increasing intracellular concentrations of phosphate and increasing the force of muscular contractions
US20100124587A1 (en) * 2008-11-17 2010-05-20 Heuer Marvin A Creatine-containing vitamin and mineral composition
US20110105786A1 (en) * 2009-11-02 2011-05-05 Tianjin Tiancheng Pharmaceutical Co., Ltd. Creatinol o-phosphate and synthesis method thereof
CN103429234B (zh) 2010-12-10 2016-10-05 布罗迪健康科学有限公司 茉莉酮酸酯治疗膀胱功能障碍的用途
CA2951567C (en) 2014-06-12 2023-10-31 Lonza, Inc. Method for decreasing skeletal muscle damage and/or oxidative stress in mammals
US10499682B2 (en) 2014-08-25 2019-12-10 New Age Beverage Corporation Micronutrient formulation in electronic cigarettes
BR112018007434A2 (pt) 2015-10-27 2018-10-23 Cytozyme Animal Nutrition Inc composições para nutrição animal, usos e métodos relacionados
US10674746B2 (en) 2015-10-27 2020-06-09 Cytozyme Animal Nutrition, Inc. Animal nutrition compositions and related methods
EP3389385A1 (en) 2015-12-18 2018-10-24 Lonza Inc. Method and composition for increasing muscle protein synthesis and/or functional strength in mammals as well as method of producing a composition
WO2022215085A1 (en) 2021-04-06 2022-10-13 Celagenex Research (India) Pvt. Ltd. A synergistic composition for potentiating stabilized atp

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU518617B2 (en) * 1977-04-29 1981-10-08 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Therapeutic application of acetyl-d, 1-carnitine
IT1124697B (it) * 1979-10-26 1986-05-14 Simes Derivati di creatinolo o-fosfato ad azione terapeutica,procedimento per la sua preparazione e relativ-e composizioni farmaceutiche
US6080788A (en) * 1997-03-27 2000-06-27 Sole; Michael J. Composition for improvement of cellular nutrition and mitochondrial energetics
IT1291127B1 (it) * 1997-04-01 1998-12-29 Sigma Tau Ind Farmaceuti Integratore alimentare per soggetti dediti ad intensa e prolungata attivita' fisica
EP0891719A1 (en) * 1997-07-14 1999-01-20 N.V. Nutricia Nutritional composition containing methionine
WO1999051097A1 (en) * 1998-04-02 1999-10-14 Avicena Group, Inc. Compositions containing a combination of a creatine compound and a second agent
ES2146555B1 (es) * 1999-01-22 2001-03-01 Helsint S A L Empleo de formulaciones a base de fracciones hidrosolubles de phlebodium decumanum (exply-37) y/o polypodium leucotomos como complemento nutricional en la prevencion y reversion del sindrome de sobresfuerzo fisico.

Also Published As

Publication number Publication date
ES2216931T3 (es) 2004-11-01
DK1196046T3 (da) 2004-08-02
NO20020337L (no) 2002-03-22
TNSN00161A1 (fr) 2005-11-10
DE60009704T2 (de) 2005-04-14
AU6468700A (en) 2001-02-13
TR200200179T2 (tr) 2002-06-21
SK942002A3 (en) 2002-05-09
PT1196046E (pt) 2004-08-31
AR024820A1 (es) 2002-10-23
CA2377128C (en) 2009-09-22
NO20020337D0 (no) 2002-01-22
ITRM990467A1 (it) 2001-01-23
PL204743B1 (pl) 2010-02-26
HU228838B1 (en) 2013-06-28
CZ20023A3 (cs) 2002-06-12
AU778647B2 (en) 2004-12-16
HUP0202298A2 (en) 2002-10-28
IT1306173B1 (it) 2001-05-30
US6602512B1 (en) 2003-08-05
ATE263496T1 (de) 2004-04-15
HUP0202298A3 (en) 2005-07-28
IL147408A0 (en) 2002-08-14
CA2377128A1 (en) 2001-02-01
DE60009704D1 (de) 2004-05-13
EP1196046A1 (en) 2002-04-17
ITRM990467A0 (it) 1999-07-23
EP1196046B1 (en) 2004-04-07
WO2001006873A1 (en) 2001-02-01
MXPA02000780A (es) 2002-08-20

Similar Documents

Publication Publication Date Title
HUP0202298A3 (en) Composition for the prevention of muscle fatigue and skeletal muscle adaptation to strenuous exercise
TW330417U (en) Improved wrist exerciser
HUP0102546A3 (en) Neuroprotective composition for the prevention and/or treatment of nervous and behavioural alterations due to anxiety states or depression
GB9724813D0 (en) Reducing muscle fatigue
GB2314782B (en) Muscle exerciser
AU7255198A (en) Methods and compositions for the prevention and treatment of muscle cramps and improving muscular strength in athletes
GB0302882D0 (en) Improvements in or relating to agents for the treatment of cardiovascular dysfunction and weight loss
AU1800801A (en) Exercise and muscle enhancement formulations
AU5591700A (en) Exercise grips attached to shoes
EP0871521A4 (en) IMPROVEMENTS RELATING TO THE TENNIS GAME
GB9919682D0 (en) Improvements relating to muscle toner pads
EP1450666A4 (en) METHOD AND COMPOSITIONS FOR TREATING HEART CIRCULAR ILLNESSES USING 139,258,1261,1486,2398,2414,7660,8587,10183,10550,12680,17921,32248,60489 OR 93804
GB2347871B (en) Specialised rehabilitation and exercise machine
GB0105085D0 (en) Improvements in or relating to fire-fighter training
TW361271U (en) Exercising ski for muscle exercising of waist
TW381501U (en) Exerciser with multiform of exercise effect
TW340388U (en) Addition 1 to the hip exerciser
TW353972U (en) Improvement of batting exerciser for boxer
TW328231U (en) Thigh sporting exerciser
TW376768U (en) Structure of the grip exerciser
IL152611A0 (en) Methods and compositions for the treatment and prevention of smooth muscle cell proliferation
GB9722565D0 (en) Respiratory muscle trainer
TW327813U (en) Hip training exerciser
GB9414711D0 (en) Improvements to muscle training devices
GB9715070D0 (en) Inspiratory muscle trainer